Target intelligence / Profile preview

Serpin family A member 1 Z-allele messenger RNA (SERPINA1-Z mRNA) (SERPINA1-Z mRNA)

Target
SERPINA1-Z mRNA
Molecular classification
Other, Messenger RNA
01

Overview

Serpin family A member 1 (SERPINA1) Z-allele messenger RNA is the transcript produced from the mutated SERPINA1 gene, specifically carrying the G-to-A point mutation that results in a glutamic acid to lysine substitution at position 342 (Glu342Lys) [UniProt P01009]. This mutation characterizes the Z-allele, the most common cause of severe Alpha-1 Antitrypsin Deficiency (AATD). The resulting Z-alpha-1 antitrypsin (Z-AAT) protein is prone to misfolding and polymerization within the endoplasmic reticulum of hepatocytes, preventing its secretion into the circulation [Strnad et al., 2020, NEJM]. This leads to a dual pathology: a toxic gain-of-function in the liver due to intracellular polymer accumulation causing cirrhosis, and a loss-of-function in the lungs due to the lack of circulating protease inhibitor, leading to emphysema. Therapeutic interventions targeting the Z-allele mRNA, such as siRNAs like fazirsiran and RNA editing tools like WVE-006, aim to reduce the production of the toxic protein at the source [Turner et al., 2024, Lancet; Wave Life Sciences, 2023]. By silencing or correcting this specific mRNA, these treatments seek to alleviate liver proteotoxicity and prevent the progression of liver disease in affected individuals.

Other names
AAT-Z mRNAAlpha-1 antitrypsin Z-mutation mRNAPI*Z mRNA transcriptSERPINA1 Glu342Lys mRNA
02

Mechanism of action

RNA interference (RNAi) mediated degradation, RNA editing, and antisense-mediated translational inhibition.

03

Biological functions

OtherProtein synthesisGenetic information transfer
04

Disease associations

OtherAlpha-1 antitrypsin deficiencyLiver cirrhosisHepatocellular carcinomaLiver fibrosis
05

Safety considerations

Potential exacerbation of pulmonary emphysema due to further reduction of circulating alpha-1 antitrypsinOff-target effects of RNA-based therapeuticsInjection site reactionsTransient liver enzyme elevations
06

Interacting drugs

Fazirsiran (TAK-999/ARO-AAT)

2 more in the full profile.

07

Biomarkers

Serum Z-alpha-1 antitrypsin (Z-AAT) levelsLiver stiffness (FibroScan)Alanine aminotransferase (ALT)Intrahepatic Z-AAT polymer concentration

Beyond the preview

Go deeper on Serpin family A member 1 Z-allele messenger RNA (SERPINA1-Z mRNA) (SERPINA1-Z mRNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Serpin family A member 1 Z-allele messenger RNA (SERPINA1-Z mRNA) (SERPINA1-Z mRNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call